Clinical Trial Update: A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study of Orca-Q for patients with hematologic malignancies undergoing allogeneic stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Mixed Phenotype Acute Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Orca-Q

Snippet

Sponsor: Orca Biosystems, Inc. | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 1 | Status: RECRUITING